On behalf of FreedomWorks’ activist community, I urge you to contact your senators and urge them to cosponsor the Federal Reserve Transparency Act, S. 573. Introduced by Sen. Rand Paul (R-Ky.), the Federal Reserve Transparency Act would require a full audit of the Federal Reserve by the Government Accountability Office.

On behalf of FreedomWorks’ activist community, I urge you to contact your representative and urge them to cosponsor the Federal Reserve Transparency Act, H.R. 24, if he or she hasn’t already done so. Introduced by Rep. Thomas Massie (R-Ky.), the Federal Reserve Transparency Act would require a full audit of the Federal Reserve by the Government Accountability Office.

Welcome to FreedomWorks’ latest blog series, Trump Appointee of the Week! From now until Election Day, we will highlight one of President Trump’s political appointees and their accomplishments. Check back every other week for the next edition and let us know who you want to see named the next Trump Appointee of the Week!

On behalf of FreedomWorks’ activist community, I urge you to contact your representative and ask him or her to cosponsor the Federal Reserve Sunshine Act, H.R. 8007, introduced by Reps. Mark Green (R-T.N.) and Tulsi Gabbard (D-Hawaii). This bill would simply eliminate the provision of the recently-passed Coronavirus Aid, Relief, and Economic Security (CARES) Act that allows the Federal Reserve to hold closed-door meetings about its newly-created $450 billion bailout fund, which is more vital now than ever as we continue to observe the alarming lack of transparency that has come along with the Federal Reserve’s new authorities.

As we attempt to recover from the economic devastation wrought by the pandemic and the government’s authoritarian response to it, restoring a sound monetary policy may not be near the top of lawmakers’ priorities -- but it should be. With record rates of deficit spending and a record-shattering Federal Reserve balance sheet, it should be no surprise that the dollar’s value is at an all time low when compared to the value of gold. None of this is setting the stage for a rapid recovery, or for robust growth thereafter.

On Friday, President Trump issued three executive orders (and threatened a fourth) outlining sweeping changes he planned to make regarding prescription drug prices in the United States. One order seeks to make federal grants to federally qualified health centers contingent upon discounted insulin prices. A second would allow personal and wholesale importation of prescription drugs from overseas. The third implements rebate reform for pharmacy benefits managers (PBMs).

Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee, the U.S. pays roughly four times as much as 11 similar nations for prescription drugs. For millions of patients, families, and caregivers, this is unacceptable. Policymakers are right when they say something needs to be done.